BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 34958665)

  • 1. Critical role of Lama4 for hematopoiesis regeneration and acute myeloid leukemia progression.
    Cai H; Kondo M; Sandhow L; Xiao P; Johansson AS; Sasaki T; Zawacka-Pankau J; Tryggvason K; Ungerstedt J; Walfridsson J; Ekblom M; Qian H
    Blood; 2022 May; 139(20):3040-3057. PubMed ID: 34958665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skin mesenchymal niches maintain and protect AML-initiating stem cells.
    Sandhow L; Cai H; Leonard E; Xiao P; Tomaipitinca L; Månsson A; Kondo M; Sun X; Johansson AS; Tryggvason K; Kasper M; Järås M; Qian H
    J Exp Med; 2023 Oct; 220(10):. PubMed ID: 37516911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells.
    Kouzi F; Zibara K; Bourgeais J; Picou F; Gallay N; Brossaud J; Dakik H; Roux B; Hamard S; Le Nail LR; Hleihel R; Foucault A; Ravalet N; Rouleux-Bonnin F; Gouilleux F; Mazurier F; Bene MC; Akl H; Gyan E; Domenech J; El-Sabban M; Herault O
    Oncogene; 2020 Feb; 39(6):1198-1212. PubMed ID: 31649334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
    Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
    Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemia.
    Wang A; Zhong H
    Hematology; 2018 Dec; 23(10):729-739. PubMed ID: 29902132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct roles of mesenchymal stem and progenitor cells during the development of acute myeloid leukemia in mice.
    Xiao P; Sandhow L; Heshmati Y; Kondo M; Bouderlique T; Dolinska M; Johansson AS; Sigvardsson M; Ekblom M; Walfridsson J; Qian H
    Blood Adv; 2018 Jun; 2(12):1480-1494. PubMed ID: 29945938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the plasticity of mesenchymal stromal cells to reroute the course of acute myeloid leukemia.
    Borella G; Da Ros A; Borile G; Porcù E; Tregnago C; Benetton M; Marchetti A; Bisio V; Montini B; Michielotto B; Cani A; Leszl A; Campodoni E; Sandri M; Montesi M; Bresolin S; Cairo S; Buldini B; Locatelli F; Pigazzi M
    Blood; 2021 Aug; 138(7):557-570. PubMed ID: 34010415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal adipogenic signaling in the bone marrow mesenchymal stem cells contributes to supportive microenvironment for leukemia development.
    Sabbah R; Saadi S; Shahar-Gabay T; Gerassy S; Yehudai-Resheff S; Zuckerman T
    Cell Commun Signal; 2023 Oct; 21(1):277. PubMed ID: 37817179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute myeloid leukemia (AML)-derived mesenchymal stem cells induce chemoresistance and epithelial-mesenchymal transition-like program in AML through IL-6/JAK2/STAT3 signaling.
    Lu J; Dong Q; Zhang S; Feng Y; Yang J; Zhao L
    Cancer Sci; 2023 Aug; 114(8):3287-3300. PubMed ID: 37272257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1β inhibits normal hematopoietic expansion and promotes acute myeloid leukemia progression via the bone marrow niche.
    Wang Y; Sun X; Yuan S; Hou S; Guo T; Chu Y; Pang T; Luo HR; Yuan W; Wang X
    Cytotherapy; 2020 Mar; 22(3):127-134. PubMed ID: 32024607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosome-shuttled FTO from BM-MSCs contributes to cancer malignancy and chemoresistance in acute myeloid leukemia by inducing m6A-demethylation: A nano-based investigation.
    Kou R; Li T; Fu C; Jiang D; Wang Y; Meng J; Zhong R; Liang C; Dong M
    Environ Res; 2024 Mar; 244():117783. PubMed ID: 38048862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mesenchymal niche remodeling impairs hematopoiesis via stanniocalcin 1 in acute myeloid leukemia.
    Waclawiczek A; Hamilton A; Rouault-Pierre K; Abarrategi A; Albornoz MG; Miraki-Moud F; Bah N; Gribben J; Fitzgibbon J; Taussig D; Bonnet D
    J Clin Invest; 2020 Jun; 130(6):3038-3050. PubMed ID: 32364536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of Mettl3 in mesenchymal stem cells promotes acute myeloid leukemia resistance to chemotherapy.
    Liao X; Cai D; Liu J; Hu H; You R; Pan Z; Chen S; Xu K; Dai W; Zhang S; Lin X; Huang H
    Cell Death Dis; 2023 Dec; 14(12):796. PubMed ID: 38052820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.
    Diaz de la Guardia R; Lopez-Millan B; Lavoie JR; Bueno C; Castaño J; Gómez-Casares M; Vives S; Palomo L; Juan M; Delgado J; Blanco ML; Nomdedeu J; Chaparro A; Fuster JL; Anguita E; Rosu-Myles M; Menéndez P
    Stem Cell Reports; 2017 Jun; 8(6):1573-1586. PubMed ID: 28528702
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gap Junctions in the Bone Marrow Lympho-Hematopoietic Stem Cell Niche, Leukemia Progression, and Chemoresistance.
    Singh AK; Cancelas JA
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 31991829
    [No Abstract]   [Full Text] [Related]  

  • 17. Adipogenic Mesenchymal Stromal Cells from Bone Marrow and Their Hematopoietic Supportive Role: Towards Understanding the Permissive Marrow Microenvironment in Acute Myeloid Leukemia.
    Le Y; Fraineau S; Chandran P; Sabloff M; Brand M; Lavoie JR; Gagne R; Rosu-Myles M; Yauk CL; Richardson RB; Allan DS
    Stem Cell Rev Rep; 2016 Apr; 12(2):235-44. PubMed ID: 26649729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.
    Zhu XN; Wei YS; Yang Q; Liu HR; Zhi Z; Zhu D; Xia L; Hong DL; Yu Y; Chen GQ
    J Hematol Oncol; 2023 Feb; 16(1):9. PubMed ID: 36774506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron Oxide Nanoparticles Combined with Cytosine Arabinoside Show Anti-Leukemia Stem Cell Effects on Acute Myeloid Leukemia by Regulating Reactive Oxygen Species.
    Dou J; Li L; Guo M; Mei F; Zheng D; Xu H; Xue R; Bao X; Zhao F; Zhang Y
    Int J Nanomedicine; 2021; 16():1231-1244. PubMed ID: 33633448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over expression of ubiquitin-conjugating enzyme E2O in bone marrow mesenchymal stromal cells partially attenuates acute myeloid leukaemia progression.
    Tian C; Chen Z; Wang L; Si J; Kang J; Li Y; Zheng Y; Gao Y; Nuermaimaiti R; You MJ; Zheng G
    Br J Haematol; 2023 Feb; 200(4):476-488. PubMed ID: 36345807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.